These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32239450)

  • 21. Divergent prion strain evolution driven by PrP
    Le Dur A; Laï TL; Stinnakre MG; Laisné A; Chenais N; Rakotobe S; Passet B; Reine F; Soulier S; Herzog L; Tilly G; Rézaei H; Béringue V; Vilotte JL; Laude H
    Nat Commun; 2017 Jan; 8():14170. PubMed ID: 28112164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.
    Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M
    J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
    Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
    Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
    Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
    Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propagation of PrP
    Chang SC; Hannaoui S; Arifin MI; Huang YH; Tang X; Wille H; Gilch S
    Commun Biol; 2023 Nov; 6(1):1162. PubMed ID: 37964018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cofactors influence the biological properties of infectious recombinant prions.
    Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
    Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of antisera to purified prions in lipid rafts.
    Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
    Prion; 2010; 4(2):94-104. PubMed ID: 20647769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Baskakov IV
    PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization of a prion strain of synthetic origin requires multiple serial passages.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    J Biol Chem; 2012 Aug; 287(36):30205-14. PubMed ID: 22807452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.
    Asthana A; Baksi S; Ashok A; Karmakar S; Mammadova N; Kokemuller R; Greenlee MH; Kong Q; Singh N
    Sci Rep; 2017 Aug; 7(1):9600. PubMed ID: 28851903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical prion disease induced by oral inoculation.
    Thackray AM; Klein MA; Bujdoso R
    J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.